Abstract B098: Unbiased in vitro and in vivo drug anchor screens identify mechanisms of resistance and sensitization for MTA-cooperative PRMT5 inhibitors in MTAP-deleted cancer modelsSteven Lombardo, Teng Teng, Matthew R. Tonini et al.|Molecular Cancer Therapeutics|2023Cited by 0
Abstract C048: Inducible activation of sgRNA libraries in tumor xenografts empowers large-scale in vivo target discovery screensSilvia Fenoglio, Teng Teng, Samuel R. Meier et al.|Molecular Cancer Therapeutics|2023Cited by 0
Abstract 5584: Experimental ‘loss-of function’ annotation of STK11 mutations with prognostic and therapeutic implications (TNG260mutationfinder.com)Leanne G. Ahronian, Teng Teng, Preksha Shahagadkar et al.|Cancer Research|2024Cited by 0
Abstract 4252: Genetic and pharmacological disruption of the HBS1L/PELO complex impairs mRNA homeostasis and leads to in vivo tumor regressions in FOCAD-deleted cancersLauren Martires, Hilary E. Nicholson, M. Tonini et al.|Cancer Research|2025Cited by 0
Temporal control of sgRNA library activation unlocks large-scale <i>in vivo</i> CRISPR screensSilvia Fenoglio, Teng Teng, Yi Yu et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0